Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy | NeoGenomics Laboratories

Publication date

Wed, 07/10/2024 - 12:00

Category

Year

Subtitle

Journal for ImmunoTherapy of Cancer

External link

https://jitc.bmj.com/content/jitc/12/7/e009368.full.pdf

Division